Contact the Editorial Desk

Editorial correspondence

Peptide Renewal Serum takes correspondence about the research record: an inaccurate citation, a newly published study on GHK-Cu, GLOW, or Melanotan II, or a change in regulatory status that should be reflected on the references page. This is the most useful category of message this desk receives.

The most actionable messages specify three things: the page in question, the exact passage being challenged, and a supporting source — a DOI or PubMed identifier where possible. That format lets a proposed correction be checked against its source before anything changes.

Editorial mailbox: editors@peptiderenewalserum.com

What this desk cannot do

This site is a literature digest, not a clinical service. It cannot advise on, or comment on, human use of any peptide covered here. It cannot suggest a dose, schedule, or route of administration for any individual. It cannot evaluate whether a cited study's finding applies to a specific person's situation. It cannot sell, source, or help locate any compound from any supplier. It cannot provide guidance for athletes subject to anti-doping rules, beyond stating a compound's published regulatory status.

GHK-Cu's topical form is a cosmetic ingredient; GLOW and Melanotan II are unapproved research chemicals. Anyone seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may take time; the mailbox is checked intermittently.